To view or add a comment, sign in Inventage Lab secures patent for long-acting injectable version of oral obesity drug orforglipron Inventage Lab, a company specializing in drug delivery platform technologies, announced on January 28 that it has secured a patent in Korea for its technology enabling the formulation of orforglipron, a small-molecule compound garnering attention as a next-generation therapy for obesity and diabetes, into a long-acting injectable dosage form
if a bezoar keeps food from moving to the small intestine, gastroparesis can be life-threatening
Can I use this service for conditions not on the list
[9] For weight management, semaglutide (Wegovy) may be prescribed through specialist weight management services for eligible patients with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities) and is typically prescribed for up to 2 years (NICE TA875)
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
doi: 10.1111/j.1467-789X.2004.00144.x 8 BlherM